Evidence map›Paper›PMID 40679370›Full record

ArticleRadiology. Imaging cancer2025

A Scoring System for Risk Stratification in Intrahepatic Cholangiocarcinoma after Immunotherapy.

Gengyun Miao, Tingting Mu, Fei Li, Jingjing Liu, Liheng Liu

Abstract read
In one paragraph

Article in Radiology. Imaging cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Gengyun Miao *Department of Radiology, Zhongshan Hospital, Fudan University, No. 180 Fenglin Road, Shanghai 200032, China.ORCID 0000-0002-0276-4034
Tingting Mu *Department of Radiology, Dongying People's Hospital, Shandong, China.ORCID 0009-0003-0288-9376
Fei LiDepartment of Radiology, Dongying People's Hospital, Shandong, China.ORCID 0009-0000-1561-8901
Jingjing LiuDepartment of Radiology, Zhongshan Hospital, Fudan University, No. 180 Fenglin Road, Shanghai 200032, China.ORCID 0009-0005-5762-0977
Liheng LiuDepartment of Radiology, Zhongshan Hospital, Fudan University, No. 180 Fenglin Road, Shanghai 200032, China.ORCID 0000-0002-3666-279X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose To identify clinical and radiologic factors associated with outcomes and develop a prognostic scoring system for patients with proficient mismatch repair or microsatellite stable intrahepatic cholangiocarcinoma (iCCA) undergoing preoperative immunotherapy. Materials and Methods This retrospective study included patients who underwent MRI and immunotherapy before surgery at a tertiary referral academic center between October 2019 and May 2023. Least absolute shrinkage and selection operator regression was performed to identify relevant clinical and radiologic features associated with recurrence-free survival (RFS), followed by multivariable Cox proportional hazards analysis to construct a nomogram incorporating all independent prognostic factors. Performance of the nomogram model was assessed using the concordance index, and RFS was analyzed using Kaplan-Meier curves and log-rank testing. Results This study included 77 patients (45 male patients) with a median age of 60 years (IQR: 51-66 years). Least absolute shrinkage and selection operator regression identified 14 potential factors, and multivariable Cox analysis determined seven independent prognostic factors: male sex (hazard ratio [HR]: 2.1,

Indexed as

Bile Duct NeoplasmsCholangiocarcinomaImmunotherapyMagnetic Resonance ImagingAgedFemaleHumansMaleMiddle AgedNomogramsPrognosisRetrospective StudiesRisk AssessmentAbdomen/GIMR ImagingOutcomes Analysis

Identifiers

PMID40679370
PMCPMC12304536

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.